- Capricor Therapeutics (NASDAQ:CAPR) is scheduled to announce Q4 earnings results on Wednesday, March 15th, after market close.
- The consensus EPS Estimate is -$0.34 and the consensus Revenue Estimate is $0M
Capricor Therapeutics Q4 2022 Earnings Preview
Recommended For You
More Trending News
About CAPR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CAPR | - | - |
Capricor Therapeutics, Inc. |